Noble Energy Closes Sale of 7.5 Percent Working Interest in Tamar

Mar 14, 2018 11:38 am UTC| Business

Houston, March 14, 2018 -- Noble Energy, Inc. (NYSE: NBL) today announced the closing of the previously announced divestment of a 7.5 percent working interest in the Tamar field, offshore Israel, to Tamar...

New Research: Key Drivers of Growth for Jazz Pharmaceuticals, Armstrong World Industries, Banco Latinoamericano de Comercio Exterior, S.A, Mercury, Canadian National Railway, and Bank of Nova Scotia — Factors of Influence, Major Initiatives and Sustained

Mar 14, 2018 11:35 am UTC| Business

NEW YORK, March 14, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Jazz...

Barrick Announces Nomination of Patricia A. Hatter as Independent Director

Mar 14, 2018 11:30 am UTC| Business

TORONTO, March 14, 2018 -- Barrick Gold Corporation (NYSE:ABX) (TSX:ABX) (Barrick or the “Company”) today announced the nomination of Patricia A. Hatter for election as a new independent director at the Company’s 2018...

Cellular Biomedicine Group Announces Upcoming Presentation to Release 48-Week Data from Phase I Clinical Trial for AlloJoin™ Off-the-Shelf Allogeneic Stem Cell Therapy for Knee Osteoarthritis

Mar 14, 2018 11:30 am UTC| Business

SHANGHAI, China and CUPERTINO, Calif., March 14, 2018 -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for...

Research Report Identifies VimpelCom, NetEase, Altisource Portfolio Solutions S.A., CyrusOne, Global Indemnity, and ChemoCentryx with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

Mar 14, 2018 11:30 am UTC| Business

NEW YORK, March 14, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of VimpelCom Ltd....

Actinium Pharmaceuticals Announces Appointment of Jehan Rowlands, Pharm.D. as Vice-President, Head of Regulatory Affairs

Mar 14, 2018 11:30 am UTC| Business

Dr. Rowlands joins Actinium with almost two decades of experience as a regulatory affairs strategist specialized in the development of first-in-class therapeutics for the treatment of rare and/or serious conditions with...

Nature’s Sunshine Products Reports Fourth Quarter 2017 Financial Results

Mar 14, 2018 11:30 am UTC| Business

Fourth quarter net sales of $88.3 million were up 5.2 percent year-over-year The fourth quarter net loss attributable to common shareholders is expected to range between $17.0 and $18.0 million, or $0.90 to $0.95 per...